Funding Opportunities

submenu

Extramural grant review opportunity available

Writing a grant? Need another set of eyes?

The Masonic Cancer Center Science Council can appoint individuals to review cancer center faculty members' grant drafts* or grant ideas in a face-to-face setting or in writing, depending on the stage of grant development. The goal is to improve upon members' success in obtaining grants funded by the NCI, ACS, and other national cancer research organizations.

To request a review, contact Elizabeth Fedie, efedie@umn.edu, 624-0653.

*Members should submit their ideas or abstracts and specific aims one cycle (~3-4 months minimum) before the grant is due. We will usually provide feedback within 1 week.

News and notices

New Topic Areas for FY16: Bladder Cancer, Lymphoma, Pediatric Brain Tumors and Immunotherapy

The FY16 Defense Appropriations Act provides $50 million to the Department of Defense Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research.

The PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY16 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in April and July 2016. Pre-application and application deadlines will be available when the Program Announcements are released.

Learn more about this opportunity


NOT-OD-16-031

This notice informs the biomedical and health services research community of planned changes to the PHS Research Performance Progress Report (RPPR) instructions for all annual non-competing (Type 5) NIH & AHRQ awards that support research activities.

These updates to address Rigor and Transparency will take effect for RPPRs due on or after January 25, 2016.

Updates to NIH & AHRQ Research Performance Progress Reports (RPPR)


Lab Size and Strategic Support of Science: Thoughts on Finding the Right Mix

Suppose a funding agency happens to have some extra money and needs to decide how to invest it. Should it invest that extra money in a large, highly productive laboratory, so that laboratory can expand a bit more? Or should it invest that extra money in a small to moderate size laboratory? Given our inability to predict the future with great certainty, which approach represents the smarter investment strategy? Jon Lorsch, the director of the National Institute for General Medical Sciences (NIGMS), has posted an interesting video on just this question.

Continue reading


NOT-PM-16-001

On November 17, the NIH issued the first set of funding opportunities associated with the implementation of the NIH Precision Medicine Initiative ® (PMI) Cohort Program. These included four  funding opportunity announcements for cooperative agreements, and two funding opportunities for Other Transaction awards. Together, the projects these funding opportunities support will build a solid infrastructure for the PMI Cohort Program.

Access all funding opportunities supporting the PMI Cohort Program through the NIH PMI Funding Opportunities page.


NOT-PM-16-001

On November 17, the NIH issued the first set of funding opportunities associated with the implementation of the NIH Precision Medicine Initiative ® (PMI) Cohort Program. These included four  funding opportunity announcements for cooperative agreements, and two funding opportunities for Other Transaction awards. Together, the projects these funding opportunities support will build a solid infrastructure for the PMI Cohort Program.

Access all funding opportunities supporting the PMI Cohort Program through the NIH PMI Funding Opportunities page.


NOT-TR-15-020

Notice of Corrections to PAR-15-173 "Pre-Application for Collaborative Innovation Award, CTSA Program (X02)"

Learn more about this notice


Consideration of Sex as a Biological Variable in NIH-funded Research

Sex and gender play a role in how health and disease processes differ across individuals, and consideration of these factors in research studies informs the development and testing of preventive and therapeutic interventions in both sexes.  This notice focuses on NIH's expectation that scientists will account for the possible role of sex as a biological variable in vertebrate animal and human studies.

Learn more about this notice: NOT-OD-15-102


NIH & AHRQ Announce Upcoming Changes to Policies, Instructions and Forms for 2016 Grant Applications

The planned changes focus on the following areas:

  • Rigor and transparency in research
  • Vertebrate animals
  • Inclusion reporting
  • Data safety monitoring
  • Research training
  • Appendices
  • Font requirements
  • Biosketch clarifications

Some of the new policies require additional data collection and updates to application forms, with phase one implemented for due dates on or after Jan. 25th, 2016 and phase two implemented for due dates on or after May 25th, 2016.

Learn more about the upcoming changes for this notice NOT-OD-16-004


Enhancing Reproducibility through Rigor and Transparency

NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability.  The key to the successful application of that knowledge toward health outcomes is scientific rigor in conducting biomedical research.

Learn more about NOT-OD-15-103


NIH Fiscal Policy for Grant Awards - FY2015

Find information about the NIH Fiscal Policy for Grant Awards - FY2015


Reminder: Biosketch Requirements for Due Dates On or After May 25, 2015

Remember, the modified biosketch format is required for applications submitted to NIH for due dates on or after May 25, 2015. Biosketch format pages, instructions, samples and FAQs are available on the Biosketches section of the SF424 (R&R) Forms and Applications page.

Learn more


NIH Increases Salary Cap to $183,300

National Institutes of Health
(NOT-OD-15-049)

Learn more about this increased salary cap


Ruth L. Kirschstein National Research Service Award (NRSA)

(NOT-OD-15-048)
National Institutes of Health

Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2015

External funding opportunities

PAR-16-338

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01)
This funding opportunity encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
Funding: Application budgets should reflect the actual needs of the proposed project. The maximum project period is 5 years.
Key Dates:
Full application due October 5, 2016


Career Catalyst Research Grants (CCR)
Susan G. Komen
CCR Grants provide unique opportunities for scientists who have held faculty positions for no more than five years at the time of Application to achieve research independence. CCR grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer. There are two research focus areas: Basic/Translational and Clinical.
Basic/Translational Research:
This award mechanism provides support for junior faculty proposing research projects that are laboratory- or field- based and do not meet Komen's definition of clinical research. Studies focusing on quality of life or survivorship issues are not appropriate for this mechanism.
Clinical Research:
This award mechanism provides support for junior faculty for patient-oriented research projects that involve direct interactions with human subjects/patients. This includes studies such as therapeutic interventions or clinical trials.
Funding: $450,000 combined direct and indirect costs; ($150,000 per year for up to 3 years)
Key Dates:
Letter of Intent due July 14, 2016 (1pm EST)
Full application due November, 22, 2016 (1pm EST)
 
Postdoctoral Fellowship Grants
Susan G. Komen
PDF Grants are intended to attract and preserve today’s young scientists and clinicians who will fuel the future and become the next generation of leaders in the field of breast cancer research. These leaders will play key roles in reducing breast cancer incidence and mortality within the next decade, with the ultimate goal of ending breast cancer forever. There are 2 Research Focus Areas: Basic/Translational and Clinical.
Basic/Translational Research:
This grant mechanism provides support for research projects that are laboratory- or field- based and do not meet Komen's definition of clinical research. Studies focusing on quality of life or survivorship issues are not appropriate for this mechanism.
Clinical Research:
This grant mechanism provides support for fellows proposing clinical, patient-oriented research projects that involve direct interactions with human subjects/patients. This includes studies such as therapeutic interventions or clinical trials.
Funding: Up to $180,000 direct costs only; ($60,000 per year for 2 to 3 years)
Key Dates:
Letter of Intent due July 14, 2016 (1pm EST)
Full application due November 22, 2016 (1pm EST)


Graduate Training in Disparities Reasearch (GTDR)
Susan G. Komen
GTDR Grants are intended to establish and/or to sustain a training program for a minimum of three graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups. GTDR Grants will only be a one step process for FY17 and will not require a Letter of Intent. The Request for Applications (RFA) will be released later this summer.
Funding: Up to $135,000 per year, direct costs only, for up to 3 years
Key Dates:
Full application due September 2016.


Clinical Consortium Research Site Award
Department of Defense Prostate Cancer Research Program
The Clinical Consortium Research Site Award provides the support to develop and enhance
collaborations and resources necessary for a network of organizations to rapidly execute Phase II or Phase II-linked Phase I (Phase I/II) prostate cancer clinical trials. These trials will include
investigations of high-impact, novel therapeutic agents or approaches for the management or
treatment of prostate cancer, especially as pertaining to the FY16 PCRP overarching challenges. In accordance with PCRP goals, the conduct of Phase I/II trials that incorporate investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer is particularly encouraged.
Funding: $200,000
Key Dates:
Pre-application deadline: September 15, 2016, 5 p.m. ET
Full application: October 11, 2016, 11:59 p.m. ET


PAR-16-338

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01)
This funding opportunity encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
Funding: Application budgets should reflect the actual needs of the proposed project. The maximum project period is 5 years.
Key Dates:
Full application due October 5, 2016


PA-16-294

NIH Support for Conferences and Scientific Meetings (Parent R13)
The purpose of the NIH Research Conference Grant (R13) is to support high quality scientific conferences that are relevant to the NIH's mission and to the public health. A conference is defined as a symposium, seminar, workshop, or any other organized and formal meeting, whether conducted face-to-face or via the internet, where individuals assemble (or meet virtually) for the primary purpose to exchange technical information and views or explore or clarify a defined subject, problem, or area of knowledge, whether or not a published report results from such meeting. The NIH recognizes the value to members of the research community and all other interested parties in supporting such forums. Support of conferences is contingent on the fiscal and programmatic interests and priorities of the individual NIH Institutes and Centers (ICs). Therefore, a conference grant application is required to contain a permission-to-submit letter from any one of the participating ICs’ conference grant contact person (see Contacts List). Applicants are urged to initiate contact well in advance of the chosen application due date and no later than 6 weeks before that date. Please note that agreement to accept an application does not guarantee funding. In general, NIH will not issue a conference grant award unless the Federal award date can precede the conference start date.
Key Dates:
Full application due August 12, 2016


PA-16-307
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
NIH/NCI
The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. NRSA fellowships support the training of pre-and postdoctoral scientists, dual-degree investigators, and senior researchers.
Funding: Award budgets are composed of stipends, tuition and fees, and institutional allowance.
Key Dates:
Full application due August 8, 2016.


AACR Judah Folkman Career Development Award for Angiogenesis Research

American Association for Cancer Research
The AACR Judah Folkman Career Development Award for Angiogenesis Research represents a joint effort to encourage and support a junior faculty researcher to conduct tumor angiogenesis research and establish a successful career path in this field. The research proposed for funding may be basic, translational, or clinical in nature, and must substantially advance the field of tumor angiogenesis. ​Proposed research projects can be basic, translational, or clinical in nature, and must substantially advance the field of tumor angiogenesis.
Funding: $150,000 over two years ($75,000 per year)
Key Dates:
Full application due July 19, 2016


 AACR-Genentech BioOncology Fellowship for Cancer Research on the HER Family Pathway
American Association for Cancer Research
The AACR-Genentech BioOncology Fellowship for Cancer Research on the HER Family Pathway represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct cancer research on the HER Family Pathway and establish a successful career path in this field. Proposed research projects may be basic, translational, or clinical in nature, and must have direct applicability to the HER Family Pathway in cancer.
Funding: $100,000 over two years ($50,000 per year)
Key Dates:
Full application due July 19, 2016


 AACR-Bristol-Myers Squibb Fellowships in Translational Immuno-oncology
American Association for Cancer Research
The AACR-Bristol-Myers Squibb Fellowships in Translational Immuno-oncology represent a joint effort to encourage and support postdoctoral or clinical research fellows to conduct innovative immuno-oncology research and to establish a successful career path in this field. ​Proposed research projects must be translational in nature and must focus on evaluating the use of the immune system to improve the lives of patients with cancer.
Funding: $110,000 over two years ($55,000 per year)
Key Dates:
Full application due July 19, 2016


QuadW Foundation-AACR Fellowship for Clinical/Translational Sarcoma Research
American Association for Cancer Research
The QuadW Foundation‐AACR Fellowship for Clinical/Translational Sarcoma Research represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct translational or clinical sarcoma research and to establish a successful career path in this field. Research projects must be clinical or translational in nature and must have direct applicability and relevance to sarcoma. Proposed research projects should be aimed toward developing personalized, therapeutic options for the treatment of sarcoma patients. Investigators utilizing novel experimental tools and techniques geared toward better understanding sarcoma in an effort to elucidate the mechanisms of currently available therapies, and/or to identify new therapeutic targets are encouraged to apply. Emphasis will be placed on proposals involving research with immediate clinical applications, including those with predictive biomarker studies.
Funding: $50,000 (one-year grant)
Key Dates:
Full application due July 26, 2016


Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment

PAR-16-212 (R01) and PAR-16-213 (R21)

NIH/NCI

This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as “chemobrain.” A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.

Funding:

(R01) - Maximum project period is 5 years. Application budgets should reflect the actual needs of the proposed project.
(R21) - The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Key Dates:

Full application due date for both the (R01) and (R21) is October 13, 2016.


Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions

PAR-16-202 (R01) and PAR-16-201 (R21)

NIH/NCI

The purpose of this Funding Opportunity Announcement (FOA) is to provide support for innovative and promising intervention research designed to improve smoking cessation outcomes among socioeconomically disadvantaged populations. Specifically, this FOA is intended to stimulate research efforts aimed at the development of smoking cessation interventions that: 1) are targeted to socioeconomically disadvantaged populations, and 2) could be made scalable for broad population impact. Applicants may propose projects that develop and test novel cessation interventions with the potential to be scaled up, as well as projects that focus on enhancing the effectiveness, quality, accessibility, utilization, and cost-effectiveness of currently scaled smoking cessation interventions. This FOA provides funding for up to 2 years for protocol development and early phase, pilot, or exploratory projects.

Funding:

(R01) - Maximum project period is 5 years. Application budgets should reflect the actual needs of the proposed project.
(R21) - The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Key Dates:

Full application due date for both the (R01) and (R21) is October 11, 2016.


Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention

PAR-15-308 - (R01) and PAR-15-309 - (R21)

This Funding Opportunity Announcement (FOA), encourages research projects focused on adducts to cellular macromolecules as indicators of exposures to cancer risk factors relevant to human populations. The priority is on projects that will focus on adductomic approaches, i.e., address some aspects of the totality of adducts. These projects should explore the basic aspects of adducts/adductomics that may have a potential utility in cancer detection, cancer prevention, and/or assessing cancer risks. The projects should be relevant to adducts in humans and human populations but may be conducted using various model systems (e.g., cultured cells, animals, etc.). The use of human biospecimens is encouraged and expected if appropriate but not required. In well-justified cases, innovative studies using the adductomic approaches in the context of cancer etiology and/or gene-environment interaction research may also be appropriate. For projects intended for NIEHS support, the focus may be on innovative technology and method development.

Funding:

R01 budgets are not limited but need to reflect the actual needs of the proposed project.
R21 budgets may not exceed $275,000.  No more than $200,000 in a single year

Key Dates:

Full Applications due July 11, 2016 for both that R01 and R21.


Detection of Pathogen-Induced Cancer (DPIC) (R01)

PAR-13-190

This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to encourage research projects which focus on the interactions of carcinogenic pathogens with the human microbiome and the host for the detection of pathogen-induced cancer (DPIC). This FOA encourages research to assess molecular signatures associated with risk and early detection of pathogen-induced cancer and chronic inflammation associated with progression to invasive cancer.

Funding:

Application budgets are not limited, but need to reflect actual needs of the proposed project.

Key Dates:

Full application due July 10, 2016


Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)

(NOT-OD-15-044)
(PAR-15-075)
National Cancer Institute

Funding:

Standard R01 limits apply

Application Receipt Date(s):

Standard dates apply, by 5:00 PM local time of applicant organization.


NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

(PAR-15-064)
National Cancer Institute

Funding:

$100,000/yr towards salary; $30,000/yr for other expenses

Application Receipt Date(s):

Multiple dates, see announcement.


NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08)

(PAR-15-060)
National Cancer Institute

Funding:

$100,000/yr towards salary; $30,000/yr for other expenses

Application Receipt Date(s):

Multiple dates, see announcement.


NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)

(PAR-15-062)
National Cancer Institute

Application Receipt Date(s):

Multiple dates, see announcement.

Funding:

$100,000/yr towards salary; $30,000/yr for other expenses


National Cancer Institute Program Project Applications (P01)

(PAR-15-023)
National Cancer Institute

Application Receipt Date(s):

Multiple dates, see announcement.

Funding:

Varies. 


Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2016 (P50)

(PAR-14-353)
National Cancer Institute

Application Receipt Date(s):

May 19, 2016; September 22, 2016

Funding:

$2,300,000 total costs/year 


Advancing Interventions to Improve Medication Adherence

PA-14-334 – R01 and PA-14-335 – R21

National Cancer Institute

Application Receipt Date(s):

Multiple dates, see announcement.

Funding:

Standard R01 & R21 limit


Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)

(PAR-14-242)
National Cancer Institute

Application Receipt Date(s):  

See announcement for dates.

Funding:

Standard R01 limits apply 


Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)

(PAR-14-260)
National Cancer Institute

Application Receipt Date(s):

May 12, 2016, See announcement for additional dates.

Funding:

Standard R01 limits apply.


Genomic Resource Grants for Community Resource Projects (U41)

(PAR-14-191)
National Cancer Institute

Funding:

5 years of funding.  Application budgets are not limited, but should reflect the needs of the proposed project.

Application Receipt Date(s):

May 25, 2016; September 25, 2016; January 25, 2017


Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)

(PA-14-114)
National Cancer Institute

Funding:

Standard R01 limits apply.

Application Receipt Date(s):

Multiple dates, see announcement.


Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)

(PAR-14-013)
National Cancer Institute

Funding:

Standard R21 limits apply

Deadline:

See announcement for dates.  


Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)

(PAR-14-116)
National Cancer Institute

Funding:

$500,000/yr for 5 years

Application Receipt Date(s):

Multiple dates, see announcement 


Modeling Social Behavior (R01)

(PAR-13-374)
National Cancer Institute

Funding:

Standard R01 limits apply

Deadline:

Multiple dates, see announcement.


Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)

(PAR-13-375)
National Cancer Institute

Funding:

Standard R01 limits apply.

Deadline:

March 22, 2016


Pancreatic Cancer Action Network Research Grants Program

Sponsor:

Pancreatic Cancer Action Network and American Association for Cancer Research

Funding is available for postdoctoral/clinical research fellows as well as for junior and senior independent researchers. The proposed research must be directly relevant to pancreatic cancer. More information about the grants program, including eligibility criteria and application due dates and procedures, is available at http://www.pancan.org/2014grants.

Funding:

See announcement

Deadlines:

Multiple; see announcement


 

Research to Characterize and Reduce Stigma to Improve Health

R01 (PA-13-248), R03 (PA-13-247) and R21 (PA-13-246)

National Cancer Institute

Funding:

Standard limits apply.

Application Receipt Date(s):

Multiple dates, see announcement.  Standard cycle dates.


Prostate Cancer Research Program (PCRP)

Sponsor:

Department of Defense

Funding:

See announcements

Deadlines:

Various; see announcements


Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness

R01 (PA-13-165), R15 (PA-13-166) and R21 (PA-13-167)

National Cancer Institute

Funding:

Standard limits apply. See announcements for additional information

Application Receipt Date(s):

Multiple dates, see announcement.


Bioengineering Research Grants (BRG) (R01)

(PAR-13-137)
National Cancer Institute

Funding:

Standard R01 limits apply.

Application Deadline: 

Multiple receipt dates, see announcement.


Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01)

(PAR-13-169)
National Cancer Institute

Funding:

standard R01 limits apply

Application Receipt Date(s):

Multiple dates, see announcement.

MCC and UMN funding opportunities

Masonic Cancer Center Internal Funding Opportunities

  • Internal Grants Program Spring 2016 (application period closed)
  • American Cancer Society’s Institutional Research Grant University of Minnesota (application period closed) 

Other University of Minnesota Funding Opportunities

Funding resources

Federal agencies funding cancer-related research

Search funding opportunities; sign up to receive the NIH Guide weekly via e-mail.

Search for funding sources by keyword; sign up for e-mail notification of funding opportunities. (Note: NIH listings are under DHHS, the Department of Health and Human Services.)

Non-federal agencies funding cancer-related research

Research funding directories

CFDA is a database of all federal programs available to state and local governments; federally recognized Indian tribal governments; territories (and possessions) of the United States; domestic public, quasi-public, and private profit and nonprofit organizations and institutions; specialized groups; and individuals.

This funding opportunity search engine provides the world's most comprehensive funding resource, with more than 24,000 records representing nearly 400,000 opportunities ranging from local non-profit funding to federally funded grants.

This is a sortable database of current funding opportunities pulled from various databases. It boasts a user-friendly interface and a comprehensive listing. While the listing is not as comprehensive as other databases in this list, opportunities may be easier to find in this abbreviated format.

(requires x.500 login)

The premier grantseeking database on the Web, developed by the Foundation Center, a national nonprofit service organization founded over 50 years ago to open up U.S. foundations to public view.

A fee-based service, to which the University of Minnesota is a current subscriber. It currently contains over 9,000 active federal and private funding opportunities in the sciences, social sciences, arts, and humanities. In addition to funding opportunities for faculty, the IRIS Database also contains fellowships and scholarships for grad students and undergrads. Users can search IRIS by sponsor, deadline date, keyword, and other criteria. Most IRIS records contain live links to sponsor Web sites, electronic forms, or Electronic Research Administration (eRA) portals. The IRIS Database is updated daily.

InfoEd's SPIN is the most widely used funding opportunity database in the world. By aggregating sponsor information in one system, SPIN dramatically cuts search times and substantially increases the likelihood of positive results. Program information is presented in a standard format that allows investigators to readily compare opportunities. This search engine is great for post-doctoral associates looking for funding opportunities.